Related Experiment Video
Updated: Jan 31, 2026

An Ex Vivo Brain Slice Model to Study and Target Breast Cancer Brain Metastatic Tumor Growth
Published on: September 22, 2021
The role of transforming growth factor-beta in primary brain tumors
1Department of Medicine, Division of Neurology, Duke University Medical Center, Durham, NC 27710, USA. rich0001@mc.duke.edu
Abstract:
Dramatic therapeutic benefits of targeting specific signal transduction pathways in some cancers have pushed rational molecular targeting to the forefront of cutting-edge cancer therapy. The identification and targeting of pathways critical to the phenotype of cancers offers new hope in the treatment of many patients. Transforming growth factor beta (TGF-beta) is a multifunctional cytokine that is frequently expressed in multiple types of malignant brain tumors. TGF-beta exerts a complex set of effects in cancers with an early tumor suppressive effect through growth inhibition but later effects in cancer development that are tumorigenic - including increased tumor cell motility and invasion, induction of angiogenesis, and immune suppression. Early preclinical and clinical studies have shown promise of anti-TGF-beta strategies in the treatment of malignant gliomas suggesting TGF-beta may be a potential new therapeutic target in neuro-oncology.
Insights
Targeting transforming growth factor beta (TGF-beta) shows promise for treating malignant gliomas. This cytokine plays a dual role in cancer, offering potential as a novel therapeutic target in neuro-oncology.
Area of Science:
- Oncology
- Molecular Biology
- Neuro-oncology
Background:
- Targeting signal transduction pathways offers novel cancer therapies.
- Transforming growth factor beta (TGF-beta) is implicated in various cancers, including brain tumors.
Purpose of the Study:
- To explore the therapeutic potential of targeting TGF-beta in malignant gliomas.
- To investigate the role of TGF-beta in tumor progression and its implications for neuro-oncology.
Main Methods:
- Review of preclinical and clinical studies on anti-TGF-beta strategies.
- Analysis of TGF-beta's multifaceted effects in cancer development.
Main Results:
- TGF-beta exhibits early tumor-suppressive effects and later pro-tumorigenic activities.
- Increased tumor cell motility, angiogenesis, and immune suppression are linked to TGF-beta signaling.
Conclusions:
- Anti-TGF-beta strategies demonstrate promise in treating malignant gliomas.
- TGF-beta represents a potential therapeutic target for neuro-oncological conditions.
Related Concept Videos
Factors Influencing Microbial Growth: Osmolarity
Factors Influencing Microbial Growth: Temperature
Factors Influencing Microbial Growth: pH
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Primary and Secondary Growth in Roots and Shoots
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...

